LCN2 and End Stage Liver Disease: We found that hepatic LCN2 gene expression positively correlated with the main prognostic scores in patients with AH, including the Age/Bilirubin/International normalized ratio/Creatinine (ABIC) score (r = 0.41, p = 0.002) and the Model for End-stage Liver Disease (MELD) score (r = 0.41, p = 0.002) (Fig. 1b).